Melissa Mae Rhodes
Engineering at Reservoir Blvd, Minneapolis, MN
License number
Louisiana EI.0018617
Issued Date
Dec 22, 1998
Expiration Date
Mar 31, 2013
Category
Civil Engineer
Address
Address
4320 Reservoir Blvd, Minneapolis, MN 55421
Personal information
See more information about Melissa Mae Rhodes at radaris.comName
Address
Phone
4440 Jefferson St NE, Minneapolis, MN 55421
4440 Jefferson St NE, Minneapolis, MN 55421
4320 Reservoir Blvd, Minneapolis, MN 55421
1901 Beaumont St, Saint Paul, MN 55117
Professional information
See more information about Melissa Mae Rhodes at trustoria.com
Household Coordinator At Rhodesco
Household Coordinator At Rhodesco
Position:
Household Coordinator at RhodesCo
Location:
Greater Minneapolis-St. Paul Area
Industry:
Medical Devices
Work:
RhodesCo
since Nov 2007
-
Household Coordinator
SDK Software Inc
Mar 2010 - Jan 2011
-
Technical Writer
Medtronic
Mar 2001 - Nov 2007
-
Sr. Systems Engineer
Medtronic
Jun 1999 - Mar 2001
-
Firmware Verification/Test Engineer
Education:
Louisiana Tech University 1994 - 1998
Bachelor of Science (BS), Biomedical Engineering Paint Branch High School 1991 - 1994
Bachelor of Science (BS), Biomedical Engineering Paint Branch High School 1991 - 1994
Methods And Apapratus For Manually Suspending Intrathoracic Impedance Fluid Status Measurements
Methods And Apapratus For Manually Suspending Intrathoracic Impedance Fluid Status Measurements
US Patent:
2012030, Nov 29, 2012
Filed:
Aug 9, 2012
Appl. No.:
13/570858
Inventors:
Holly S. Vitense - Maple Grove MN, US
Li Wang - Hong Kong, CN
Denise Dirnberger - Blaine MN, US
Melissa M. Rhodes - Columbia Heights MN, US
Douglas A. Hettrick - Andover MN, US
Shantanu Sarkar - St. Paul MN, US
Li Wang - Hong Kong, CN
Denise Dirnberger - Blaine MN, US
Melissa M. Rhodes - Columbia Heights MN, US
Douglas A. Hettrick - Andover MN, US
Shantanu Sarkar - St. Paul MN, US
Assignee:
Medtronic, Inc. - Minneapolis MN
International Classification:
A61N 1/365
US Classification:
607 28
Abstract:
The capability to suspend a patient alert relating to a monitored physiologic parameters addresses a need to selectively shut off a patient-alert signal or signals during the time a patient is being treated for an excursion in the parameter. Of course, in general a signal call attention to a patient's a potentially deleterious status or condition for which they should seek medical attention. Once a chronically-implanted monitoring device has detected or provided information about the parameter relative to a desired value, trend, or range and a clinician has been notified and intervened the alert signal is temporarily disabled for a predetermined period. That is, once the notification occurs and alert has served its purpose, the alert mechanism is selectively deactivated while the patient ostensibly begins to gradually correct the monitored physiologic parameter under a caregiver's direction and control. After which time, the alert will reactivate.
Methods And Apparatus For Manually Suspending Intrathoracic Impedance Fluid Status Measurements
Methods And Apparatus For Manually Suspending Intrathoracic Impedance Fluid Status Measurements
US Patent:
2008010, May 1, 2008
Filed:
Oct 31, 2006
Appl. No.:
11/554825
Inventors:
Holly S. Vitense - Maple Grove MN, US
Li Wang - Hong Kong, CN
Denise Dirnberger - Blaine MN, US
Melissa M. Rhodes - Columbia Heights MN, US
Douglas A. Hettrick - Andover MN, US
Shantanu Sarkar - St. Paul MN, US
Li Wang - Hong Kong, CN
Denise Dirnberger - Blaine MN, US
Melissa M. Rhodes - Columbia Heights MN, US
Douglas A. Hettrick - Andover MN, US
Shantanu Sarkar - St. Paul MN, US
International Classification:
A61N 1/00
US Classification:
607 2
Abstract:
The capability to suspend a patient alert relating to a monitored physiologic parameters addresses a need to selectively shut off a patient-alert signal or signals during the time a patient is being treated for an excursion in the parameter. Of course, in general a signal call attention to a patient's a potentially deleterious status or condition for which they should seek medical attention. Once a chronically-implanted monitoring device has detected or provided information about the parameter relative to a desired value, trend, or range and a clinician has been notified and intervened the alert signal is temporarily disabled for a predetermined period. That is, once the notification occurs and alert has served its purpose, the alert mechanism is selectively deactivated while the patient ostensibly begins to gradually correct the monitored physiologic parameter under a caregiver's direction and control. After which time, the alert will reactivate.